Klinische Forschung
Achtung: Diese Seite kann nur von Administratoren besucht werden, da Sie nicht freigeschalten wurde.
Publications Berger Christoph

Anaphylaxis to Goat's and Sheep's Milk in an Adult Who Tolerated Cow's Milk: A Sensitization Profile Study.

Hirsiger JR; Heijnen IA; Hartmann K; Berger CT. Journal of investigational allergology & clinical immunology. 2022.

A Simplified PET/CT Measurement Routine with Excellent Diagnostic Accuracy for the Diagnosis of Giant Cell Arteritis.

Imfeld S; Scherrer D; Mensch N; Aschwanden M; Staub D; Berger CT; Daikeler T; Rottenburger C. Diagnostics. 2022.

Investigating potential mechanisms underlying FVIII inhibition in acquired hemophilia A associated with mRNA COVID-19 vaccines.

Hirsiger JR; Martinez M; Tsakiris DA; Cittone MG; Graf L; Oldenburg J; Pezeshkpoor B; Recher M; Mueller J; Gerber B; Berger CT. . 2022.

Passive immunization against COVID-19 by anti-SARS-CoV-2 spike IgG in commercially available immunoglobulin preparations in severe antibody deficiency.

Hirsiger JR; Weigang S; Walz AC; Fuchs J; Daly ML; Eggimann S; Hausmann O; Schwemmle M; Kochs G; Panning M; Warnatz K; Recher M; Berger CT. Journal of Allergy and Clinical Immunology: In Practice. 2022.

Safe administration of subsequent mRNA COVID-19 vaccine doses following a possible allergic reaction to the first dose

Roth M.S.; Chantraine S.; Morales Mateluna C.A.; Hartmann K.; Berger C.T.. Journal of the European Academy of Dermatology and Venereology. 2022.

Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data.

Hemmig AK; Gozzoli D; Werlen L; Ewald H; Aschwanden M; Blockmans D; Brouwer E; Buchanan RRC; Camellino D; Campochiaro C; Cimmino MA; Corominas H; Gloy V; Henckaerts L; Kyburz D; Moya-Alvarado P; Owen CE; Stegert M; Tomelleri A; van Sleen Y; Yamashita H; Imfeld S; Berger CT; Hemkens LG; Daikeler T. Seminars in arthritis and rheumatism. 2022.

Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases.

Raptis CE; Berger CT; Ciurea A; Andrey DO; Polysopoulos C; Lescuyer P; Maletic T; Riek M; Scherer A; von Loga I; Safford J; Lauper K; Möller B; Vuilleumier N; Finckh A; Rubbert-Roth A. Frontiers in Immunology. 2022.

[Update and practical advice for travel vaccinations and consultations in primary care].

Güdel DS; Berger CT. Therapeutische Umschau. 2021.

Chronic inflammation and extracellular matrix-specific autoimmunity following inadvertent periarticular influenza vaccination.

Hirsiger JR; Tamborrini G; Harder D; Bantug GR; Hoenger G; Recher M; Marx C; Li QZ; Martin I; Hess C; Scherberich A; Daikeler T; Berger CT. Journal of Autoimmunity. 2021.

Complications and cost estimations in herpes zoster - a retrospective analysis at a Swiss tertiary dermatology clinic.

Bongers LD; Navarini A; Berger CT; Mueller SM. Swiss medical weekly. 2021.

Immune thrombocytopenia associated with COVID-19 mRNA vaccine tozinameran - a clinical case and global pharmacovigilance data.

Battegay R; Istampoulouoglou I; Holbro A; Buser A; Hirsiger JR; Eckstein J; Berger CT; Koechlin S; Leuppi-Taegtmeyer AB. Swiss medical weekly. 2021.

JAK Inhibition in a Patient with X-Linked Reticulate Pigmentary Disorder.

Légeret C; Meyer BJ; Rovina A; Deigendesch N; Berger CT; Daikeler T; Heijnen I; Burstein E; Köhler H; Recher M. Journal of Clinical Immunology. 2021.

Smartphone-based active vaccine safety surveillance (SmartVax) at a Swiss adult vaccination clinic - a pilot study.

Guedel DS; Peters IJ; Banderet F; Epple V; Egli S; Mehling M; Mayr M; Leeb A; Berger CT. Swiss medical weekly. 2021.

The Meaning of SARS-CoV-2 Antibodies in a Patient with a Systemic Reaction to the mRNA-1273 SARS-CoV-2 Vaccine after Previous Natural Immunization.

Sazgary L; Meienberg A; Berger CT; Mayr M. European journal of case reports in internal medicine. 2021.

The statistical risk of diagnosing coincidental acquired hemophilia A following anti-SARS-CoV-2 vaccination.

Cittone MG; Battegay R; Condoluci A; Terzi di Bergamo L; Fernandes E; Galfetti E; Noseda R; Leuppi-Taegtmeyer A; Drexler B; Ceschi A; Tsakiris DA; Berger CT; Favre G; Martin T; Korte W; Graf L; Martinez M; Gerber B. . 2021.

The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination.

Haaf P; Kuster GM; Mueller C; Berger CT; Monney P; Burger P; Stämpfli SF; Attenhofer Jost CH; Zellweger MJ; Osswald S; Donner BC; Koestner SC; Tanner FC. Swiss medical weekly. 2021.

Throat swelling following tocilizumab infusion-not always angioedema.

Baenziger-Sieber P; Daikeler T; Negoias S; Berger CT. Rheumatology advances in practice. 2021.

[18F]FDG positron emission tomography and ultrasound in the diagnosis of giant cell arteritis: congruent or complementary imaging methods?

Imfeld S; Aschwanden M; Rottenburger C; Schegk E; Berger CT; Staub D; Daikeler T. Rheumatology (United Kingdom). 2020.

A simple clinical score to identify likely hepatitis B vaccination non-responders - data from a retrospective single center study.


Case Report-Secondary Antibody Deficiency Due to Endogenous Hypercortisolism.

Sarcevic J; Cavelti-Weder C; Berger CT; Trendelenburg M. . 2020.

Co-Occurrence of ANCA-Associated Vasculitis and Sjögren's Syndrome in a Patient With Acromegaly: A Case Report and Retrospective Single-Center Review of Acromegaly Patients.

Fuchs PS; Lötscher J; Berkemeier CM; Hirsiger JR; Ghosh A; Li QZ; Deigendesch N; Christ E; Navarini AA; Recher M; Daikeler T; Heijnen IAFM; Berger CT. Frontiers in Immunology. 2020.

Longitudinal versus cross-sectional IL-6 measurements in tocilizumab-treated GCA. Response to: 'Analysis of IL-6 measurement in GCA patients treated with tocilizumab should consider concomitant treatment with prednisone' by Samson and Bonnotte.

Berger CT; Daikeler T. Annals of the Rheumatic Diseases. 2020.

Tumoural soft tissue calcification in Down syndrome: association with heterozygous germline SAMD9 mutation and hyperactive type I interferon signaling.

Deigendesch N; Hirsiger JR; Bigler MB; Ghosh A; Harder D; Jauch A; Espinosa JM; Recher M; Navarini A; Daikeler T; Berger CT. Rheumatology (United Kingdom). 2020.

Febrile illness and bicytopenia within hours after tick-borne encephalitis booster vaccination.

Bühler T; Boos N; Leuppi-Taegtmeyer AB; Berger CT. npj Vaccines. 2019.

Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapses.

Berger CT; Rebholz-Chaves B; Recher M; Manigold T; Daikeler T. Annals of the Rheumatic Diseases. 2019.

Syphilis Reactivates Latent Epstein-Barr Virus Reservoir via Toll-Like Receptor 2 and B-Cell Receptor Activation.

Hirsiger JR; Fuchs PS; Häusermann P; Müller-Durovic B; Daikeler T; Recher M; Hirsch HH; Terracciano L; Berger CT. Open Forum Infectious Diseases. 2019.

The target uric acid level in multimorbid patients with gout is difficult to achieve: data from a longitudinal Swiss single-centre cohort.

Ankli B; Berger CT; Haeni N; Kyburz D; Hügle T; So AK; Daikeler T. Swiss medical weekly. 2019.

Vessel wall plasticity in large vessel giant cell arteritis: an ultrasound follow-up study.

Aschwanden M; Schegk E; Imfeld S; Staub D; Rottenburger C; Berger CT; Daikeler T. Rheumatology (United Kingdom). 2019.

[18F]FDG positron emission tomography in patients presenting with suspicion of giant cell arteritis-lessons from a vasculitis clinic.

Imfeld S; Rottenburger C; Schegk E; Aschwanden M; Juengling F; Staub D; Recher M; Kyburz D; Berger CT; Daikeler T. European heart journal. Cardiovascular Imaging. 2018.

ADCC-Mediated CD56(DIM) NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV Infection.

Yu WH; Cosgrove C; Berger CT; Cheney PC; Krykbaeva M; Kim AY; Lewis-Ximenez L; Lauer GM; Alter G. Pathogens & immunity. 2018.

Calcium pyrophosphate deposition disease: a frequent finding in patients with long-standing erosive gout.

Ankli B; Kyburz D; Hirschmann A; Hügle T; Manigold T; Berger CT; Daikeler T. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2018.

Computational Strategies for Dissecting the High-Dimensional Complexity of Adaptive Immune Repertoires.

Miho E; Yermanos A; Weber CR; Berger CT; Reddy ST; Greiff V. Frontiers in Immunology. 2018.

Immune system correlates of extensive limb swelling in response to conjugated pneumococcal vaccination.

Recher M; Hirsiger JR; Bigler MB; Iff M; Lemaître B; Scherer K; Häusermann P; Siegrist CA; Berger CT. npj Vaccines. 2018.

Interleukin-6 flags infection in tocilizumab-treated giant cell arteritis.

Berger CT; Recher M; Daikeler T. Rheumatology (United Kingdom). 2018.

Nano-scale microfluidics to study 3D chemotaxis at the single cell level.

Frick C; Dettinger P; Renkawitz J; Jauch A; Berger CT; Recher M; Schroeder T; Mehling M. PLoS ONE. 2018.

Serum neurofilament light chain: a biomarker of neuronal injury in vasculitic neuropathy.

Bischof A; Manigold T; Barro C; Heijnen I; Berger CT; Derfuss T; Kuhle J; Daikeler T. Annals of the Rheumatic Diseases. 2018.

The clinical benefit of imaging in the diagnosis and treatment of giant cell arteritis.

Berger CT; Sommer G; Aschwanden M; Staub D; Rottenburger C; Daikeler T. Swiss medical weekly. 2018.

Varicella zoster virus-specific T cell responses in untreated giant cell arteritis: comment on the article by England et al.

Bigler MB; Hirsiger JR; Recher M; Mehling M; Daikeler T; Berger CT. Arthritis and Rheumatology. 2018.

A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.

Carmona FD; Vaglio A; Mackie SL; Hernández-Rodríguez J; Monach PA; Castañeda S; Solans R; Morado IC; Narváez J; Ramentol-Sintas M; Pease CT; Dasgupta B; Watts R; Khalidi N; Langford CA; Ytterberg S; Boiardi L; Beretta L; Govoni M; Emmi G; Bonatti F; Cimmino MA; Witte T; Neumann T; Holle J; Schönau V; Sailler L; Papo T; Haroche J; Mahr A; Mouthon L; Molberg Ø; Diamantopoulos AP; Voskuyl A; Brouwer E; Daikeler T; Berger CT; Molloy ES; O'Neill L; Blockmans D; Lie BA; Mclaren P; Vyse TJ; Wijmenga C; Allanore Y; Koeleman BPC; Spanish CGA Group; UKGCA Consortium; Vasculitis Clinical Research Consortium; Barrett JH; Cid MC; Salvarani C; Merkel PA; Morgan AW; González-Gay MA; Martín J. American Journal of Human Genetics. 2017.

Characteristics of autoantibodies targeting 14-3-3 proteins and their association with clinical features in newly diagnosed giant cell arteritis.

Kistner A; Bigler MB; Glatz K; Egli SB; Baldin FS; Marquardsen FA; Mehling M; Rentsch KM; Staub D; Aschwanden M; Recher M; Daikeler T; Berger CT. Rheumatology (United Kingdom). 2017.

Detection of Sp110 by Flow Cytometry and Application to Screening Patients for Veno-occlusive Disease with Immunodeficiency.

Marquardsen FA; Baldin F; Wunderer F; Al-Herz W; Mikhael R; Lefranc G; Baz Z; Rezaee F; Hanna R; Kfir-Erenfeld S; Stepensky P; Meyer B; Jauch A; Bigler MB; Burgener AV; Higgins R; Navarini AA; Church JA; Chou J; Geha R; Notarangelo LD; Hess C; Berger CT; Bloch DB; Recher M. Journal of Clinical Immunology. 2017.

Low immunoglobulin E flags two distinct types of immune dysregulation.

Elkuch M; Greiff V; Berger CT; Bouchenaki M; Daikeler T; Bircher A; Navarini AA; Heijnen I; Recher M. Clinical and Experimental Immunology. 2017.

Trametinib after disease reactivation under dabrafenib in Erdheim-Chester disease with both BRAF and KRAS mutations.

Nordmann TM; Juengling FD; Recher M; Berger CT; Kalbermatten D; Wicki A; Paasinen-Sohns A; Cathomas G; Tzankov A; Daikeler T. Blood. 2017.

Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis.

Navarini AA; Hruz P; Berger CT; Hou TZ; Schwab C; Gabrysch A; Higgins R; Frede N; Padberg Sgier BC; Kämpe O; Burgener AV; Marquardsen F; Baldin F; Bigler M; Kistner A; Jauch A; Bignucolo O; Meyer B; Meienberg F; Mehling M; Jeker LT; Heijnen I; Daikeler TD; Gebbers JO; Grimbacher B; Sansom DM; Jeker R; Hess C; Recher M. Journal of Allergy and Clinical Immunology. 2017.

A 'Too Negative' ANA Test Predicts Antibody Deficiency.

Recher M; Berger CT; Daikeler T; Hess C; Heijnen IA. Journal of Clinical Immunology. 2016.

Factors associated with significant MRI findings in medical walk-in patients with acute headache.

Budweg J; Sprenger T; De Vere-Tyndall A; Hagenkord A; Stippich C; Berger CT. Swiss medical weekly. 2016.

HLA-C levels impact natural killer cell subset distribution and function.

Sips M; Liu Q; Draghi M; Ghebremichael M; Berger CT; Suscovich TJ; Sun Y; Walker BD; Carrington M; Altfeld M; Brouckaert P; De Jager PL; Alter G. Human Immunology. 2016.

Neglected for too long? - CD8+ Tregs release NOX2-loaded vesicles to inhibit CD4+ T cells.

Berger CT; Hess C. Journal of Clinical Investigation. 2016.

Diagnosis at your fingertips: splinters and microemboli--is it SLE?

Berger CT; Baldi T; Aschwanden M; Scherer K; Recher M; Hess C; Daikeler T. LUPUS. 2015.

Immune screening identifies novel T cell targets encoded by antisense reading frames of HIV-1.

Berger CT; Llano A; Carlson JM; Brumme ZL; Brockman MA; Cedeño S; Harrigan PR; Kaufmann DE; Heckerman D; Meyerhans A; Brander C. Journal of Virology. 2015.

Influenza vaccine response profiles are affected by vaccine preparation and preexisting immunity, but not HIV infection.

Berger CT; Greiff V; Mehling M; Fritz S; Meier MA; Hoenger G; Conen A; Recher M; Battegay M; Reddy ST; Hess C. Human Vaccines and Immunotherapeutics. 2015.

Risk factors for pneumocystis pneumonia in giant cell arteritis: a single-centre cohort study.

Berger CT; Greiff V; John S; Koenig KF; Bigler MB; Recher M; Hess C; Daikeler T. Clinical and Experimental Rheumatology. 2015.

Stress-Induced In Vivo Recruitment of Human Cytotoxic Natural Killer Cells Favors Subsets with Distinct Receptor Profiles and Associates with Increased Epinephrine Levels.

Bigler MB; Egli SB; Hysek CM; Hoenger G; Schmied L; Baldin FS; Marquardsen FA; Recher M; Liechti ME; Hess C; Berger CT. PLoS ONE. 2015.

The ultrasound compression sign to diagnose temporal giant cell arteritis shows an excellent interobserver agreement.

Aschwanden M; Imfeld S; Staub D; Baldi T; Walker UA; Berger CT; Hess C; Daikeler T. Clinical and Experimental Rheumatology. 2015.

[Better vaccinations - new approaches for targeted immunomodulation in healthy and immunosuppressed].

Balmer ML; Berger CT. Therapeutische Umschau. 2014.

Chronic HCV infection affects the NK cell phenotype in the blood more than in the liver.

Cosgrove C; Berger CT; Kroy DC; Cheney PC; Ghebremichael M; Aneja J; Tomlinson M; Kim AY; Lauer GM; Alter G. PLoS ONE. 2014.

Genetic variation in schlafen genes in a patient with a recapitulation of the murine Elektra phenotype.

Recher M; Karjalainen-Lindsberg ML; Lindlöf M; Söderlund-Venermo M; Lanzi G; Väisänen E; Kumar A; Sadeghi M; Berger CT; Alitalo T; Anttila P; Kolehmainen M; Franssila R; Chen T; Siitonen S; Delmonte OM; Walter JE; Pessach I; Hess C; Simpson MA; Navarini AA; Giliani S; Hedman K; Seppänen M; Notarangelo LD. Journal of Allergy and Clinical Immunology. 2014.

Incidence and prognostic implications of diplopia in patients with giant cell arteritis.

Haering M; Holbro A; Todorova MG; Aschwanden M; Kesten F; Berger CT; Tyndall A; Benz D; Hess C; Daikeler T. Journal of Rheumatology. 2014.

KIR2DL3⁺NKG2A⁻ natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs.

Thoens C; Berger C; Trippler M; Siemann H; Lutterbeck M; Broering R; Schlaak J; Heinemann FM; Heinold A; Nattermann J; Scherbaum N; Alter G; Timm J. Journal of Hepatology. 2014.

Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors.

Kroy DC; Ciuffreda D; Cooperrider JH; Tomlinson M; Hauck GD; Aneja J; Berger C; Wolski D; Carrington M; Wherry EJ; Chung RT; Tanabe KK; Elias N; Freeman GJ; de Kruyff RH; Misdraji J; Kim AY; Lauer GM. Gastroenterology. 2014.

A 17q12 allele is associated with altered NK cell subsets and function.

Xia Z; Liu Q; Berger CT; Keenan BT; Kaliszewska A; Cheney PC; Srivastava GP; Castillo IW; De Jager PL; Alter G. Journal of Immunology. 2012.

Altered distribution of mucosal NK cells during HIV infection.

Sips M; Sciaranghella G; Diefenbach T; Dugast AS; Berger CT; Liu Q; Kwon D; Ghebremichael M; Estes JD; Carrington M; Martin JN; Deeks SG; Hunt PW; Alter G. Mucosal Immunology. 2012.

CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control.

Mothe B; Llano A; Ibarrondo J; Zamarreño J; Schiaulini M; Miranda C; Ruiz-Riol M; Berger CT; Herrero MJ; Palou E; Plana M; Rolland M; Khatri A; Heckerman D; Pereyra F; Walker BD; Weiner D; Paredes R; Clotet B; Felber BK; Pavlakis GN; Mullins JI; Brander C. PLoS ONE. 2012.

IL28B polymorphisms as a pretreatment predictor of response to HCV treatment.


Single-cell analysis of the dynamics and functional outcomes of interactions between human natural killer cells and target cells.

Yamanaka YJ; Berger CT; Sips M; Cheney PC; Alter G; Love JC. Integrative Biology. 2012.

A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples.

Ackerman ME; Moldt B; Wyatt RT; Dugast AS; McAndrew E; Tsoukas S; Jost S; Berger CT; Sciaranghella G; Liu Q; Irvine DJ; Burton DR; Alter G. Journal of Immunological Methods. 2011.

Decreased Fc receptor expression on innate immune cells is associated with impaired antibody-mediated cellular phagocytic activity in chronically HIV-1 infected individuals.

Dugast AS; Tonelli A; Berger CT; Ackerman ME; Sciaranghella G; Liu Q; Sips M; Toth I; Piechocka-Trocha A; Ghebremichael M; Alter G. Virology. 2011.

Definition of the viral targets of protective HIV-1-specific T cell responses.

Mothe B; Llano A; Ibarrondo J; Daniels M; Miranda C; Zamarreño J; Bach V; Zuniga R; Pérez-Álvarez S; Berger CT; Puertas MC; Martinez-Picado J; Rolland M; Farfan M; Szinger JJ; Hildebrand WH; Yang OO; Sanchez-Merino V; Brumme CJ; Brumme ZL; Heckerman D; Allen TM; Mullins JI; Gómez G; Goulder PJ; Walker BD; Gatell JM; Clotet B; Korber BT; Sanchez J; Brander C. Journal of Translational Medicine. 2011.

High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control.

Berger CT; Frahm N; Price DA; Mothe B; Ghebremichael M; Hartman KL; Henry LM; Brenchley JM; Ruff LE; Venturi V; Pereyra F; Sidney J; Sette A; Douek DC; Walker BD; Kaufmann DE; Brander C. Journal of Virology. 2011.

Natural killer cells in spontaneous control of HIV infection.

Berger CT; Alter G. Curr Opin HIV AIDS. 2011.

Maternal laboratory stress influences fetal neurobehavior: cortisol does not provide all answers.

Fink NS; Urech C; Berger CT; Hoesli I; Holzgreve W; Bitzer J; Alder J. Journal of Maternal-Fetal and Neonatal Medicine. 2010.

Viral adaptation to immune selection pressure by HLA class I-restricted CTL responses targeting epitopes in HIV frameshift sequences.

Berger CT; Carlson JM; Brumme CJ; Hartman KL; Brumme ZL; Henry LM; Rosato PC; Piechocka-Trocha A; Brockman MA; Harrigan PR; Heckerman D; Kaufmann DE; Brander C. Journal of Experimental Medicine. 2010.

A patient's wish: anakinra in pregnancy.

Berger CT; Recher M; Steiner U; Hauser TM. Annals of the Rheumatic Diseases. 2009.

High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition.

Berger CT; Wolbers M; Meyer P; Daikeler T; Hess C. Rheumatology (United Kingdom). 2009.

Lymphocyte counts in patients with ANCA-associated vasculitis.

Holbro A; Schuetz P; Berger C; Hess C; Daikeler T. Rheumatology international. 2009.

Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy

Blyszczuk P.; Kania G.; Dieterle T.; Marty R.R.; Valaperti A.; Berthonneche C.; Pedrazzini T.; Berger C.T.; Dirnhofer S.; Matter C.M.; Penninger J.M.; Luscher T.F.; Eriksson U.. Circulation Research. 2009.

Testing the "cytokine-ome" theory: a longitudinal pilot study in renal transplant recipients.

Gasser O; Berger C; Zenhaeusern G; Elsässer H; Oehri I; Schaub S; Hess C. Transplantation. 2008.